{"id":874356,"date":"2025-08-12T06:45:43","date_gmt":"2025-08-12T10:45:43","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\/"},"modified":"2025-08-12T06:45:43","modified_gmt":"2025-08-12T10:45:43","slug":"rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\/","title":{"rendered":"Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc."},"content":{"rendered":"<div class=\"mw_release\">\n<ul>\n<li style=\"text-align:left\">\n          <strong>$20 million drawn down at closing, with access to up to an additional $25 million<\/strong>\n        <\/li>\n<\/ul>\n<ul>\n<li>\n          <strong>Strengthens Company\u2019s financial position and reinforces ability to achieve positive cash flow<\/strong>\n        <\/li>\n<\/ul>\n<p align=\"left\">LEXINGTON, Mass., Aug.  12, 2025  (GLOBE NEWSWIRE) &#8212; Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the \u201cCompany\u201d or \u201cRapid Micro\u201d), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that it has entered into a five-year, $45 million term loan facility with Trinity Capital Inc. (Nasdaq: TRIN) (\u201cTrinity Capital\u201d).<\/p>\n<p align=\"left\">Proceeds from this facility will be used for general corporate purposes, which may include supporting the continued global commercial expansion of the Growth Direct system, and ongoing investments in manufacturing efficiencies, service productivity, and product cost reduction initiatives.<\/p>\n<p align=\"left\">\u201cThis facility significantly strengthens our financial position and supports our continued focus on long-term revenue growth, margin expansion and increasing shareholder value,\u201d said Robert Spignesi, President and CEO of Rapid Micro Biosystems. \u201cWe are pleased with the highly favorable terms of this facility, which positions us well to build on our meaningful progress across the business.\u201d<\/p>\n<p align=\"left\">The loan facility consists of four tranches, with the first tranche of $20 million drawn upon closing of the agreement. The second and third tranches totaling $20 million are available to be drawn subject to the achievement of certain commercial and operational milestones, and the fourth tranche of $5 million is available at the lender\u2019s discretion. Interest is payable on the outstanding principal amount at a floating rate, initially 11.5% per annum. The loan facility has a five-year term with an interest-only period of 36 months, which is extendable if future tranches are drawn down. The loan facility contains customary representations, warranties, covenants and events of default but does not require the Company to maintain a specified level of revenues or cash resources.<\/p>\n<p align=\"left\">The Growth Direct system is the only fully automated, non-destructive growth-based platform for MQC testing that offers manufacturers faster time to results, improved data integrity and enhanced accuracy.<\/p>\n<p align=\"left\">Armentum Partners acted as the Company\u2019s exclusive financial advisor on this transaction.<\/p>\n<p align=\"left\">To learn more about the Company and the Growth Direct<sup>\u00ae<\/sup> platform, please visit our website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=O7D_m-QPT4f87oDoJCbcENbVqissUiInqypJuvEFTmO8yi4xkHuykCTHYS43UeOG7CdGE2Rb0MfRnLiNaGViKOnWK29e6PuqD1ctqNuQLuU=\" rel=\"nofollow\" target=\"_blank\"><u>Rapid Micro Biosystems<\/u><\/a>.<\/p>\n<p align=\"left\">\n        <strong>About Rapid Micro Biosystems<\/strong>\u00a0<\/p>\n<p align=\"left\">Rapid Micro Biosystems is an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The Company\u2019s flagship Growth Direct system automates and modernizes the antiquated, manual microbial quality control (\u201cMQC\u201d) testing workflows used in the largest and most complex pharmaceutical manufacturing operations across the globe. The Growth Direct system brings the quality control lab to the manufacturing floor, unlocking the power of MQC automation to deliver the faster results, greater accuracy, increased operational efficiency, better compliance with data integrity regulations, and quicker decision making that customers rely on to ensure safe and consistent supply of important healthcare products. The Company is headquartered in Lexington, Massachusetts and has U.S. manufacturing in Lowell, Massachusetts, with global locations in Switzerland, Germany, and the Netherlands. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kF5Tio3dT99mSK2FTVWCDgYYNTc5Woy4GkcGIgATgKFy6EkQbCVjw-ymsnvKk1Np6WudRRSRsBQipcRmKnKSPcTyaubmWUngtPN6rihpz7JsiPhJkYtvB4xCc7oouprMgRgaO6emN6xXBzq-6FCrEmEVZhY6OfbnZL243kEBa2ZKZTeuU2UGmhr_SW45966P1Q-WQQiYdomMcjfm4TXeeioCfgWQcOLs8M__eb6jvRM9w4Zs1w8BmJVqMCNBuLvUdAFcKRIJXwLubc0jAlHaqQ==\" rel=\"nofollow\" target=\"_blank\"><u>www.rapidmicrobio.com<\/u><\/a>\u00a0or follow the Company on X (formerly known as Twitter) at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LFSrKzqRlzqQme49Jubzq9f1rMeGxAtKR9hCE9SS870skxny7rVUc_AvGxJvzjlCHxO-V-QMVf89jdhYoP0Rf09oI3UoyLeeEUfauiuh7goHA0Et5bbJYf3r6y5LPTkddWXkuq5t0OhlInxYYxopiNBbR8Xe8hCnmUT76WW3d75yCOvlSMLV7K8BBb9UdwcMY3SzrzgZhll0Ar5HCnhK5PigvvNp8ghKXe7zaUBcTboo7O49kWKSYW-gzAA1lqEy22HN_1ful-NkszEBdS-uklGgcWJdU0FCLhqc47rFvtG7qO0JGpq5VpOMQKG-3X0bNpeHBSDPF3VqB1D1qkN0Vc-pL3LG7os1TnofEy4ZA67o76WJvwmKLsL9OhdBeCTI5_ocM8qVZtR43jzgKZ_Z2fDAdJNhNyuswhFXRYHtanGhT9YHyLEnN2nWsHp9Q5TTQRJdbdManLYV7FWQa4J5WbaC8nIkKE8vk99vL6_gHyeYUnMYryq0e1LoZw9ZUAbHEPXHWpngV7QVRHSlb9xwVbwc1bxREV9acrf57A6s-5P0dlp8XkdEneZN1iFfdGapbGGlZn0zKC0vFcYF3CoOmF7hSsYUNkb2qKJWyFO3r1RiA4ktFFtV8zDGxVbSpLzTDamk0cQut17-ih6u51lzMStwX6QgoichdQqTnCFDpdR9Wf3NSUR8L-kKQ-I4SAB8CO9pDf72QD89klqwK2GcsW_TkOIez8cMOhe8FLdbu7k=\" rel=\"nofollow\" target=\"_blank\"><u>@rapidmicrobio<\/u><\/a>\u00a0or on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ebGIwA-bSsowRlPQcANtDYKtnE9Zh951XvR37TeFFmDzmIq-3uHtvINxNR8h1Ikn3-3AQgKAGda75zoe_m9uz7EvwmwBUTYie9RJg8cNHTo0ZxPXxivCSopqMFhNezhQb_u48vzwSdAHOeMuVrrbL6zLqjgZGe3gtVSxbvArHgpw5tObh3PN5yWnZYLJRj1gxgNofhFQVUKJ5ywrS95bZeKuHBlQWTMhiLwJJ3ClOnERPlj_rQzchtxmD2SJWD72nCbwJgBLsM7kq-lQCUadAWs3rOtPV3w_UtrqlQgY1P1ul2uQ1HYxXTYxCPLBdXLgga_fB-6fv5lZOTMEH9hpoil3Q2sW0H7xzprMms821jZyxDHTqkFR3V3a2J5DBH9LRK9xVVboYE571QdAr3UEW8HMUDNbK6BDNMvyoJT7ZIbR_GjrCeoOZgpdNFGLeGC-mgrtwHyP4c3eXNgivqfAWotZAuPeJBGhJlz6F9vpJPQgeE5H0npjM8jb9iaS7wdcb4uKYxKTsPk6Hetutwght6ybDF_cd3mF1pqS5OfbXxBKn8k_GvEbkzuELxQWCBZopp2ZI070Ye2moetR3VLLPCkQ_cHi_FLSlmIszjjuOFC3jeIKxn5pYgzOJoJgwH_yaQ1_mL5TmNUiPECx4bWAgq_fxfuZltxKE7mfddqULuIIKY7E6YLcEW-GStkcNjN_DM4D8yA7VcEBvaBuRUAx8PLK1rJTJYmxvwB6ApGBADzxHt42Cda0FE53gNa0XW42\" rel=\"nofollow\" target=\"_blank\"><u>LinkedIn<\/u><\/a>.<\/p>\n<p align=\"left\">\n        <strong>Forward-Looking Statements <\/strong>\n      <\/p>\n<p align=\"left\">This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking statements, including, but not limited to, statements regarding the Company\u2019s newly-announced term loan facility, including the planned use of proceeds therefor and the intended benefits thereof.<\/p>\n<p align=\"left\">In some cases, you can identify forward-looking statements by terminology such as \u201coutlook,\u201d \u201caim,\u201d \u201canticipate,\u201d \u201cassume,\u201d \u201cbelieve,\u201d \u201ccontemplate,\u201d \u201ccontinue,\u201d \u201ccould,\u201d \u201cdue,\u201d \u201cestimate,\u201d \u201cexpect,\u201d \u201cgoal,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cobjective,\u201d \u201cplan,\u201d \u201cpredict,\u201d \u201cpotential,\u201d \u201cpositioned,\u201d \u201cseek,\u201d \u201cshould,\u201d \u201ctarget,\u201d \u201cwill,\u201d \u201cwould\u201d and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements involve known and unknown risks, uncertainties and assumptions which may cause actual results to differ materially from any results expressed or implied by any forward-looking statement, including, but not limited to, the impact of the Company&#8217;s existing and any future indebtedness on its ability to operate its business; the Company\u2019s ability to access any future tranches under its debt facility and to comply with all of its obligations thereunder; the Company\u2019s ability to achieve its goal of attaining positive cashflow; and the other important factors outlined under the caption \u201cRisk Factors\u201d in the Company\u2019s most recent Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (\u201cSEC\u201d) on May 9, 2025, as such factors may be updated from time to time in its other filings with the SEC, which are available on the SEC&#8217;s website at www.sec.gov and the Investor Relations page of its website at investors.rapidmicrobio.com. Although the Company believes that the expectations reflected in its forward-looking statements are reasonable, it cannot guarantee future results. The Company has no obligation, and does not undertake any obligation, to update or revise any forward-looking statement made in this press release to reflect changes since the date of this press release, except as may be required by law.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMDYzMCM3MDkzODQ1IzIwMTg1NjI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NzIxZWU3YWUtMTcwMS00MjBiLTkxOTUtMTViZjE1NDBiOWU3LTEwMzAxMzQtMjAyNS0wOC0xMi1lbg==\/tiny\/Rapid-Micro-Biosystems-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Rapid Micro Biosystems Investor Contact:\u00a0\r\nMichael Beaulieu, CFA\u00a0\r\nVice President, Investor Relations and Corporate Communications\u00a0\r\ninvestors@rapidmicrobio.com\r\n\r\nRapid Micro Biosystems Media Contact:\u00a0\r\nmedia@rapidmicrobio.com<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>$20 million drawn down at closing, with access to up to an additional $25 million Strengthens Company\u2019s financial position and reinforces ability to achieve positive cash flow LEXINGTON, Mass., Aug. 12, 2025 (GLOBE NEWSWIRE) &#8212; Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the \u201cCompany\u201d or \u201cRapid Micro\u201d), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that it has entered into a five-year, $45 million term loan facility with Trinity Capital Inc. (Nasdaq: TRIN) (\u201cTrinity Capital\u201d). Proceeds from this facility will be used for general corporate purposes, which may include supporting the continued global commercial expansion of the Growth Direct system, and ongoing investments in &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc.&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-874356","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc. - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc. - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"$20 million drawn down at closing, with access to up to an additional $25 million Strengthens Company\u2019s financial position and reinforces ability to achieve positive cash flow LEXINGTON, Mass., Aug. 12, 2025 (GLOBE NEWSWIRE) &#8212; Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the \u201cCompany\u201d or \u201cRapid Micro\u201d), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that it has entered into a five-year, $45 million term loan facility with Trinity Capital Inc. (Nasdaq: TRIN) (\u201cTrinity Capital\u201d). Proceeds from this facility will be used for general corporate purposes, which may include supporting the continued global commercial expansion of the Growth Direct system, and ongoing investments in &hellip; Continue reading &quot;Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc.&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-12T10:45:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMDYzMCM3MDkzODQ1IzIwMTg1NjI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc.\",\"datePublished\":\"2025-08-12T10:45:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\\\/\"},\"wordCount\":913,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxMDYzMCM3MDkzODQ1IzIwMTg1NjI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\\\/\",\"name\":\"Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc. - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxMDYzMCM3MDkzODQ1IzIwMTg1NjI=\",\"datePublished\":\"2025-08-12T10:45:43+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxMDYzMCM3MDkzODQ1IzIwMTg1NjI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTUxMDYzMCM3MDkzODQ1IzIwMTg1NjI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc.\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc. - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\/","og_locale":"en_US","og_type":"article","og_title":"Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc. - Market Newsdesk","og_description":"$20 million drawn down at closing, with access to up to an additional $25 million Strengthens Company\u2019s financial position and reinforces ability to achieve positive cash flow LEXINGTON, Mass., Aug. 12, 2025 (GLOBE NEWSWIRE) &#8212; Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the \u201cCompany\u201d or \u201cRapid Micro\u201d), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that it has entered into a five-year, $45 million term loan facility with Trinity Capital Inc. (Nasdaq: TRIN) (\u201cTrinity Capital\u201d). Proceeds from this facility will be used for general corporate purposes, which may include supporting the continued global commercial expansion of the Growth Direct system, and ongoing investments in &hellip; Continue reading \"Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc.\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\/","og_site_name":"Market Newsdesk","article_published_time":"2025-08-12T10:45:43+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMDYzMCM3MDkzODQ1IzIwMTg1NjI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc.","datePublished":"2025-08-12T10:45:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\/"},"wordCount":913,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMDYzMCM3MDkzODQ1IzIwMTg1NjI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\/","name":"Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc. - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMDYzMCM3MDkzODQ1IzIwMTg1NjI=","datePublished":"2025-08-12T10:45:43+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMDYzMCM3MDkzODQ1IzIwMTg1NjI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTUxMDYzMCM3MDkzODQ1IzIwMTg1NjI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/rapid-micro-biosystems-enters-into-five-year-45-million-term-loan-facility-with-trinity-capital-inc\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Rapid Micro Biosystems Enters into Five-Year, $45 Million Term Loan Facility with Trinity Capital Inc."}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/874356","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=874356"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/874356\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=874356"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=874356"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=874356"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}